Regeneron Pharmaceuticals
REGN
#266
Rank
S$106.77 B
Marketcap
S$1,007
Share price
0.75%
Change (1 day)
4.24%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2025 (TTM): S$6.72 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are S$14.24 Billion. In 2024 the company made an earning of S$6.13 Billion, an increase over its 2023 earnings that were of S$5.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$6.72 B9.62%
2024 S$6.13 B13.83%
2023 S$5.38 B-13.57%
2022 S$6.23 B-47.9%
2021 S$11.96 B144.75%
2020 S$4.88 B56.86%
2019 S$3.11 B-4.87%
2018 S$3.27 B22.86%
2017 S$2.66 B56.3%
2016 S$1.70 B8.55%
2015 S$1.57 B54.53%
2014 S$1.01 B11.14%
2013 S$0.91 B72.13%
2012 S$0.53 B-285.93%
2011 -S$0.29 Billion121.73%
2010 -S$0.13 Billion37.18%
2009 -S$94.03 Million-14.6%
2008 -S$0.12 Billion-25.02%
2007 -S$0.15 Billion6.32%
2006 -S$0.14 Billion-186.52%
2005 S$0.15 B2103.7%
2004 S$7.24 M-105.66%
2003 -S$0.13 Billion-18.18%
2002 -S$0.16 Billion42.33%
2001 -S$0.11 Billion129.35%
2000 -S$47.94 Million51.87%
1999 -S$31.57 Million92.19%
1998 -S$16.43 Million66.23%
1997 -S$9.88 Million-55.49%
1996 -S$22.2 Million103.53%
1995 -S$10.91 Million-70.89%
1994 -S$37.47 Million-26.08%
1993 -S$50.68 Million114.67%
1992 -S$23.61 Million196.77%
1991 -S$7.96 Million87.88%
1990 -S$4.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
S$10.57 B 60.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$0.16 B-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$2.44 B-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$41.56 B 529.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$21.06 B 219.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
S$11.67 B 76.87%๐Ÿ‡ซ๐Ÿ‡ท France